SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS

Ian J. Cohen,Helen Toledano,Jerry Stein,Yehuda Kollender,Eyal Fenig,Osnat Konen,Zvi Bar-Sever,Josephine Issakov,Meora Feinmesser,Smadar Avigad,Shifra Ash

SCMCIE94: an intensified pilot treatment protocol known to be associated with cure in CD 56-negative non-pelvic isolated Ewing sarcoma (EWS) is also associated with no early relapses in non-metastatic extremity EWS

2019

Ian J. Cohen
Helen Toledano
Jerry Stein
Yehuda Kollender
Eyal Fenig
Osnat Konen
Zvi Bar-Sever
Josephine Issakov
Meora Feinmesser
Smadar Avigad
Shifra Ash

Purpose We report the unexpected absence of early relapse (before 30 months) in 24 consecutive patients with isolated limb primary Ewing sarcoma treated with an intensified pilot protocol, SCMCIE94.

Keywords:

Early Relapse
Pharmacology
Oncology
Sarcoma
Medicine
Internal medicine
Autologous Stem Cell Rescue
Minimal residual disease
Disease
Cohort
Chemotherapy
Busulfan
Survival rate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations